Loading
Latest filing published 14 Dec 2021 for Clarus Therapeutics Holdings, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
This profile gathers the share dealings of Robert E. Dudley in Clarus Therapeutics Holdings, Inc., where the filings describe the role as chief executive. Over a trading history stretching from 9 September 2021 to 12 December 2021, the count stands at 2 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 14 December 2021 with a share grant in Clarus Therapeutics Holdings, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations